Company Description
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.
The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.
Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Country | United States |
Founded | 2005 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
Employees | 70 |
CEO | Scott G. Davis |
Contact Details
Address: 101 Glacier Point, Suite A San Rafael, California 94901 United States | |
Phone | 510-984-1761 |
Website | eksobionics.com |
Stock Details
Ticker Symbol | EKSO |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001549084 |
CUSIP Number | 282644301 |
ISIN Number | US2826443010 |
SIC Code | 3569 |
Key Executives
Name | Position |
---|---|
Scott G. Davis | Chief Executive Officer and Director |
Jerome Wong | Corporate Controller, Corporate Secretary and Chief Financial Officer |
Jason C. Jones | Chief Operating Officer |
Rachael Anderson | Global Director of Marketing and Strategic Growth |
Anthony Pratt | Vice President of Sales |
Ann Cookson | Human Resources Director |
Foon Lim Chwee | President of APAC |
Stephan Aderhold | Senior Vice President and GM of EMEA |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 29, 2024 | 10-Q | Quarterly Report |
Apr 29, 2024 | 8-K | Current Report |
Apr 26, 2024 | ARS | Filing |
Apr 26, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 26, 2024 | DEF 14A | Other definitive proxy statements |
Mar 18, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
Mar 18, 2024 | 11-K | Annual report of employee stock purchase, savings and similar plans |
Mar 4, 2024 | 10-K | Annual Report |
Mar 4, 2024 | 8-K | Current Report |
Jan 16, 2024 | 8-K | Current Report |